Revvity(RVTY) ZACKS·2025-01-31 13:11Company Performance - Revvity (RVTY) reported quarterly earnings of $1.42 per share, exceeding the Zacks Consensus Estimate of $1.36 per share, and up from $1.25 per share a year ago, representing an earnings surprise of 4.41% [1] - The company posted revenues of $729.37 million for the quarter ended December 2024, slightly missing the Zacks Consensus Estimate by 0.10%, but up from $695.9 million year-over-year [2] - Over the last four quarters, Revvity has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Market Performance - Revvity shares have increased approximately 13.7% since the beginning of the year, outperforming the S&P 500's gain of 3.2% [3] - The current consensus EPS estimate for the upcoming quarter is $1.11 on revenues of $678.51 million, and for the current fiscal year, it is $4.97 on revenues of $2.87 billion [7] Industry Outlook - The Medical Services industry, to which Revvity belongs, is currently ranked in the bottom 37% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Revvity's stock may be influenced by the overall outlook for the industry, as research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]